Targeting Aurora kinases in ovarian cancer

Author： Fu Siqing   Hu Wei   Kavanagh John J   Bast Jr Robert C  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.10, Iss.1, 2006-02, pp. : 77-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Aurora Kinases in Cancer Treatment

By  

Current Drug Targets, Vol. 12, Iss. 14, 2011-12 ,pp. : 2067-2078

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting tyrosine-kinases in ovarian cancer

By Morotti Matteo   Becker Christian M   Menada Mario Valenzano   Ferrero Simone  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1265-1279

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Aurora kinases for the treatment of cancer

By Fancelli Daniele   Moll Jürgen  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 9, 2005-09 ,pp. : 1169-1182

Informa Healthcare

Access to resources Recommend Favorite

Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 12, Iss. 2, 2012-02 ,pp. : 144-163

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting of polo-like kinases and their cross talk with Aurora kinases – possible therapeutic strategies in human acute myeloid leukemia?

By Tsykunova Galina   Reikvam Håkon   Ahmed Aymen Bushra   Nepstad Ina   Gjertsen Bjørn Tore   Bruserud Øystein  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 587-603

Informa Healthcare

Access to resources Recommend Favorite